ArticleJTCVS open2026
Bicuspid versus tricuspid aortic valve morphology in elective ascending aortic aneurysm surgery: A propensity score-matched analysis.
Article in JTCVS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To compare perioperative and long-term outcomes between bicuspid (BAV) and tricuspid (TAV) aortic valve patients undergoing elective ascending aortic aneurysm surgery using propensity score matching (PSM). Methods: We retrospectively analyzed 1340 consecutive adults who underwent elective ascending aortic surgery for aneurysm at a single high-volume center between January 2014 and December 2025. After exclusions, 816 patients (373 BAV, 443 TAV) were eligible. PSM (1:1 nearest-neighbor, caliper width 0.2 SD on the logit scale; 14 baseline covariates, including ascending aortic diameter) produced 285 matched pairs (all with standardized mean difference <0.10). Primary endpoints were 30-day and 10-year all-cause mortality; secondary endpoints included early postoperative complications and late aortic reintervention. Results: The median follow-up was 5.4 years (interquartile range, 2.6-8.1; completeness, 96.7%). Thirty-day mortality was 0.7% (n = 2 of 285) in the BAV group versus 1.05% (n = 3 of 285) in the TAV group (odds ratio, 0.66; 95% confidence interval, [CI], 0.11-3.98; Conclusions: In this propensity score-matched cohort, BAV morphology was not associated with worse perioperative or long-term outcomes after elective ascending aortic surgery compared to TAV. These findings support managing BAV-related aortopathy according to the same patient- and anatomy-driven principles used for TAV rather than based on valve morphology alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.